Department of Social Psychology, Tilburg University, Tilburg, The Netherlands; Radboud Institute for Health Sciences, Department of Primary and Community Care, Radboud University Medical Center, Nijmegen, The Netherlands.
Department of Urology, Elisabeth-Tweesteden Hospital, Tilburg, The Netherlands.
Patient Educ Couns. 2019 Mar;102(3):424-428. doi: 10.1016/j.pec.2018.10.006. Epub 2018 Oct 4.
To investigate the effect of including an online decision aid (DA) during prostate cancer treatment counseling on decisional regret and information satisfaction in a one-year follow-up.
Within a cluster RCT, 18 Dutch hospitals were randomized to DA counseling or care-as-usual, patients (n = 382) initially completed questionnaires directly after treatment decision making. Six and twelve months later regret (Decisional Regret Scale) and information satisfaction (SCIP-B) were assessed. Anxious and depressive symptoms (HADS) was included as possible covariate.
After 12 months, 43 participants (15%) regretted their treatment choice and 105 participants (36%) were dissatisfied with the information that was received at the time of decision-making, regardless of being exposed to the DA. Anxious and depressive symptoms at follow-up were associated with regret and information dissatisfaction.
No long-term benefical effects emerged from DA usage compared to patients who underwent standard counseling.
During PCa treatment counseling, healthcare providers should be aware of anxious and depressive symptoms.
探究在前列腺癌治疗咨询中纳入在线决策辅助（DA）对一年随访中决策后悔和信息满意度的影响。
在一项集群 RCT 中，18 家荷兰医院被随机分配到 DA 咨询或常规护理组，患者（n=382）在治疗决策后立即直接完成问卷。在 6 个月和 12 个月时评估后悔（决策后悔量表）和信息满意度（SCIP-B）。焦虑和抑郁症状（HADS）作为可能的协变量。
12 个月后，43 名参与者（15%）对治疗选择感到后悔，105 名参与者（36%）对决策时收到的信息不满意，无论是否接触过 DA。随访时的焦虑和抑郁症状与后悔和信息不满有关。
与接受标准咨询的患者相比，DA 的使用并未带来长期的有益效果。
在前列腺癌治疗咨询中，医疗保健提供者应注意焦虑和抑郁症状。
